Eyetronic – the first treatment of glaucoma that can improve visual fields!

Fields of Application

New hope for visual field loss: The Eyetronic Therapy has been developed for patients suffering from a progressive visual field loss due to glaucoma or other diseases of the optic nerve.

Eyetronic – the first treatment of glaucoma that can improve visual fields!

Fields of Application

New hope for visual field loss: The Eyetronic Therapy has been developed for patients suffering from a progressive visual field loss due to glaucoma or other diseases of the optic nerve.

Eyetronic Therapy

The therapy is based on the knowledge that tissue is not completely destroyed when the optic nerve is damaged. Retinal ganglion cells may survive, but are malfunctioning. By applying gentle alternating pulses which are individually adapted to the patient, the Eyetronic Therapy stimulates the metabolism of the neurons in order to restore their function and to stop further cell degeneration. The efficacy of this non-invasive therapy has been proven in clinical studies.1 Since 2014 the treatment is offered in selected centers.

 

1Gall C, Schmidt S, Schittkowski MP, Antal A, Ambrus GG, Paulus W, et al. (2016) Alternating Current Stimulation for Vision Restoration after Optic Nerve Damage: A Randomized Clinical Trial. PLoS ONE 11(6): e0156134.

Eyetronic Therapy

The therapy is based on the knowledge that tissue is not completely destroyed when the optic nerve is damaged. Retinal ganglion cells may survive, but are malfunctioning. By applying gentle alternating pulses which are individually adapted to the patient, the Eyetronic Therapy stimulates the metabolism of the neurons in order to restore their function and to stop further cell degeneration. The efficacy of this non-invasive therapy has been proven in clinical studies.1 Since 2014 the treatment is offered in selected centers.

 

1Gall C, Schmidt S, Schittkowski MP, Antal A, Ambrus GG, Paulus W, et al. (2016) Alternating Current Stimulation for Vision Restoration after Optic Nerve Damage: A Randomized Clinical Trial. PLoS ONE 11(6): e0156134.

WHAT PATIENTS SAY

  • “At the end of March 2023 I was treated with the Eyetronic therapy.
    After the treatment, I have had a positive sensation.
    I started to see things more clearly and my sight seems to be less blurred and brighter.
    I feel satisfied and I am available to undergo this treatment again.”

    Patient R.M., Summer 2023, treated in Italy with the Eyetronic Therapy

  • “In november 2021 I underwent the Eyetronic therapy.
    At the end of the treatment I noticed a visual improvement in brightness and quality of sight.
    This improvement is lasting over time.”

    Patient M.S., Summer 2023, treated in Italy with the Eyetronic Therapy

  • “I see colors more clearly now, I see better at a distance, and I can also recognize faces better again. I could not do all of that before the treatment.”

    Hans-Joerg Hehli, patient treated in Germany with the Eyetronic Therapy

  • “Right after the treatment, I noticed clear improvements and thanks to the long-term effect I could regain some of my vision throughout the following time. In the course of the first year after the therapy, there was a constant improvement in the visual field, which has continued to this day. Reading has become a lot easier as well.”

    Margrit Kulwatz, patient treated 2015 in Germany with the Eyetronic Therapy

WHAT EXPERTS SAY

  • The benefits of alternating current stimulation have been shown in neurology, and we know that the principle works. We are currently transferring this experience to the field of ophthalmology. A big advantage for patients is that the treatment is usually painless, and so far we only noticed a few temporary side effects.

    Carl Erb, MD, PhD, glaucoma expert and medical director of the Ophthalmology Clinic at Wittenbergplatz, Berlin, Germany

Therapy Centers

Contact

I agree that Neuromodtronic GmbH uses the personal information I provide to process my request through the contact form.

Downloads

Further information about the Eyetronic Therapy can be found in the following documents:

therapy@eyetronic.com
+49 355 86 95 00 40
All rights reserved.
Copyright 2024 Neuromodtronic GmbH

The Eyetronic® System is CE marked and available in selected European markets.

The Eyetronic® Therapy and the Eyetronic® System are not yet available in the United States of America.

DisclaimerPrivacy Notice